Log in
Enquire now
‌

US Patent 11535668 Inducible monovalent antigen binding protein

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Harpoon Therapeutics
Harpoon Therapeutics
Current Assignee
Harpoon Therapeutics
Harpoon Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11535668
Date of Patent
December 27, 2022
Patent Application Number
16489523
Date Filed
February 28, 2018
Patent Citations
‌
US Patent 10428120 Serum half-life extension using IgBD
‌
US Patent 10066016 Single chain variable fragment CD3 binding proteins
‌
US Patent 10100106 Single domain serum albumin binding protein
‌
US Patent 11180563 FLT3 binding proteins and methods of use
Patent Primary Examiner
‌
Phillip Gambel

Disclosed herein are inducible monovalent target-binding proteins which are activated upon protease cleavage. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are further provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11535668 Inducible monovalent antigen binding protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.